Delivery Order SPE2DB22D2211-SPE2DB25FRXTJ

Award Date 5/22/25
Potential Completion Date 6/13/25
Potential Value $5.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 120 units of the prescription drug BOSULIF 100 MG TABLET. The firm fixed price contract has a ceiling value of $5,704.45 and an ultimate completion date of June 27, 2025. The award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $23,631.26 firm fixed-price contract is for the delivery of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a Delivery Order contract worth $5,288.86 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOSULIF 500 MG TABLET 30S. This contract has an ultimate completion date of November 4, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to provide essential pharmaceutical products to support military treatment...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for the supply of BOSULIF 100 MG TABLET 120S, a pharmaceutical product, with a potential value of $9,982.56 and a completion date of March 26, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOSULIF 100 MG TABLET 120S, a prescription medication, with a ceiling value of $5,704.45. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $5,704.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,059,457 units of the prescription medication BOSULIF 100 MG TABLET 120S. The contract is a firm fixed-price, non-set-aside award with a completion date of May 19, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $10,955.43 firm fixed-price contract is for the supply of BOSULIF 400 MG TABLET 30S, a pharmaceutical product. The award has an ultimate completion date of August 29, 2024 and is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Bosulif 100 mg tablets, a medication used to treat certain types of leukemia. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $22,817.80 and a period of performance through May 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,910.86, is for the supply of BOSULIF 400 MG TABLET 30S, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and a performance period that runs through December 4, 2024. AmerisourceBergen holds a larger $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bosulif 400 mg tablets. The $23,631.26 firm-fixed-price contract has a completion date of May 27, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB25FRXTJ
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BOSULIF 100 MG TABLET 120S, a prescription medication, with a firm fixed price and a ceiling value of $5,704.45. The contract has an ultimate completion date of June 13, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 8/21/25, 9:52 AM